Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 06-05-2015 | Practice Area: | Corporate and M&A |
| Deal Title: | Sale of EpiTherapeutics ApS to Gilead Biopharmaceutics Ireland UC | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Gorrissen Federspiel assisted Novo A/S, SEED Capital Denmark K/S, Lundbeck-fond Invest A/S (all Denmark, venture capital/pharma) and Merck BV (the Netherlands, venture capital/pharma) in connection with their disposal of EpiTherapeutics ApS (Denmark, pharma) to Gilead Biopharmaceutics Ireland UC (part of the Gilead group based in California, USA, pharma).
Transaction value: DKK 471 million.
Announcement date: 6 May 2015.
|
||
| Financial Center: | Copenhagen | Value: | 0.00-100.00 |
| Advised Party: | Vendor | Law Firm | Gorrissen Federspiel |
| Target Company Jurisdiction: | Denmark | Acquiror Jurisdiction: | Ireland |
| Classification: |
Strategic Buyer Acquisitions Private Company |
Lawyer | Niels Bang |
